Royal Biologics Launches MAGNUS, a DMSO-free Viable Cellular Bone Allograft
HACKENSACK, N.J., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Royal Biologics, an orthobiologics company specializing in the research and advancement of regenerative cellular therapy and novel orthobiologic solutions, has announced the launch of MAGNUS, a DMSO-free …